SUNPHARMA had a positive weekly return of 2.44%, outperforming its peers DRREDDY and HINDUNILVR, but slightly underperforming DIVISLAB. The stock's volatility was moderate at 21.87%, lower than most of its peers. With a Sharpe Ratio of 0.44, the stock's return was relatively attractive considering its risk. Overall, SUNPHARMA's weekly performance was strong, but it still experienced a max drawdown of -0.91%, indicating some risk.

[Volatility: 21.87%]